Additionally, the complexity of the system could have been underestimated (such as the expression of potential regulators of the IGF pathway, as IGF2R in ACC) and the existence of interfering factors may not have been characterized yet. This evidence concerns the gene IGF2R and adrenal cortex carcinoma.